Literature DB >> 33603961

Sigma-1 and Sigma-2 Receptor Modulators as Potential Therapeutics for Alzheimer's Disease.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2021        PMID: 33603961      PMCID: PMC7883366          DOI: 10.1021/acsmedchemlett.1c00002

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis.

Authors:  Mireia Herrando-Grabulosa; Núria Gaja-Capdevila; José M Vela; Xavier Navarro
Journal:  Br J Pharmacol       Date:  2020-09-01       Impact factor: 8.739

Review 2.  Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease.

Authors:  Wen-Hui Ma; Ai-Fang Chen; Xiao-Yang Xie; Yun-Sheng Huang
Journal:  Neuropharmacology       Date:  2020-10-09       Impact factor: 5.250

Review 3.  Allosteric Modulators of Sigma-1 Receptor: A Review.

Authors:  Edijs Vavers; Liga Zvejniece; Tangui Maurice; Maija Dambrova
Journal:  Front Pharmacol       Date:  2019-03-19       Impact factor: 5.810

Review 4.  Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases.

Authors:  Daniel A Ryskamp; Svetlana Korban; Vladimir Zhemkov; Nina Kraskovskaya; Ilya Bezprozvanny
Journal:  Front Neurosci       Date:  2019-08-28       Impact factor: 4.677

  4 in total
  2 in total

1.  Therapeutic Properties of Ayahuasca Components in Ischemia/Reperfusion Injury of the Eye.

Authors:  Anna Szilágyi; Barbara Takács; Réka Szekeres; Vera Tarjányi; Mariann Bombicz; Dániel Priksz; Attila Kovács; Béla Juhász; Ede Frecska; Zoltán Szilvássy; Balázs Varga
Journal:  Biomedicines       Date:  2022-04-26

2.  Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.

Authors:  Antonino N Fallica; Valeria Pittalà; Maria N Modica; Loredana Salerno; Giuseppe Romeo; Agostino Marrazzo; Mohamed A Helal; Sebastiano Intagliata
Journal:  J Med Chem       Date:  2021-06-02       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.